EUR-Lex - 31978D0167 - EN

ARTICLE 1

THE COMMUNITY SHALL IMPLEMENT FOR A PERIOD OF THREE YEARS A CONCERTED PROJECT IN THE FIELD OF REGISTRATION OF CONGENITAL ABNORMALITIES , HEREINAFTER REFERRED TO AS ' THE PROJECT ' .

THE PROJECT SHALL CONSIST IN COORDINATION AT COMMUNITY LEVEL OF THE RESEARCH DESCRIBED IN ANNEX I , WHICH FORMS PART OF THE RESEARCH PROGRAMMES OF THE MEMBER STATES .

ARTICLE 2

THE COMMISSION SHALL BE RESPONSIBLE FOR SUCH COORDINATION .

ARTICLE 3

THE MAXIMUM FINANCIAL CONTRIBUTION BY THE COMMUNITY TO SUCH A PROJECT WILL BE 330 000 UNITS OF ACCOUNT , THE UNIT OF ACCOUNT BEING DEFINED BY THE RELEVANT FINANCIAL REGULATIONS .

ARTICLE 4

TO FACILITATE THE EXECUTION OF THE PROJECT , A CONCERTED ACTION COMMITTEE ON THE REGISTRATION OF CONGENITAL ABNORMALITIES , HEREINAFTER REFERRED TO AS ' THE COMMITTEE ' SHALL BE ESTABLISHED .

A PROJECT LEADER SHALL BE APPOINTED BY THE COMMISSION IN AGREEMENT WITH THE COMMITTEE . HE SHALL , IN PARTICULAR , ASSIST THE COMMISSION IN ITS COODINATING ACTION .

THE TERMS OF REFERENCE AND THE COMPOSITION OF THIS COMMITTEE ARE DEFINED IN ANNEX II .

THE COMMITTEE SHALL DRAW UP ITS RULES OF PROCEDURE . ITS SECRETARIAT WILL BE PROVIDED BY THE COMMISSION .

ARTICLE 5

IN ACCORDANCE WITH A PROCEDURE TO BE ADOPTED BY THE COMMISSION IN AGREEMENT WITH THE COMMITTEE , THE MEMBER STATE PARTICIPATING IN THE PROJECT SHALL EXCHANGE REGULARLY ALL USEFUL INFORMATION CONCERNING THE EXECUTION OF THE RESEARCH COVERED BY THE PROJECT AND FORWARD TO THE COMMISSION ALL INFORMATION THAT MAY BE USEFUL FOR COORDINATION PURPOSES . THEY SHALL ALSO ENDEAVOUR TO PROVIDE THE COMMISSION WITH INFORMATION ON SIMILAR RESEARCH PLANNED OR CARRIED OUT BY BODIES FOR WHICH THEY ARE NOT RESPONSIBLE . THIS INFORMATION SHALL BE TREATED AS CONFIDENIAL IF SO REQUESTED BY THE MEMBER STATE WHICH PROVIDES IT .

THE COMMISSION SHALL PREPARE YEARLY PROGRESS REPORTS ON THE BASIS OF THE INFORMATION SUPPLIED AND SHALL FORWARD THEM TO THE MEMBER STATES AND TO THE EUROPEAN PARLIAMENT .

AT THE END OF THE COORDINATION PERIOD , THE COMMISSION SHALL , IN AGREEMENT WITH THE COMMITTEE , FORWARD TO THE MEMBER STATES AND TO THE EUROPEAN PARLIAMENT A GENERAL REPORT ON THE EXECUTION AND RESULTS OF THE COORDINATION ACTION . THE COMMISSION SHALL PUBLISH THIS REPORT SIX MONTHS AFTER IT HAS BEEN FORWARDED TO THE MEMBER STATES UNLESS A MEMBER STATE OBJECTS . IN THIS CASE THE REPORT SHALL BE DISTRIBUTED , AT THEIR REQUEST , SOLELY TO INSTITUTIONS AND UNDERTAKINGS WHOSE RESEARCH AND PRODUCTION ACTIVITIES JUSTIFY ACCESS TO THE RESULTS OF THE RESEARCH CARRIED OUT UNDER THE PROJECT . THE COMMISSION MAY MAKE PROVISION THAT THE REPORT REMAINS CONFIDENTIAL AND IS NOT DISCLOSED TO THIRD PARTIES .

ARTICLE 6

1 . IN ACCORDANCE WITH THE PROVISIONS LAID DOWN IN ARTICLE 228 OF THE TREATY ESTABLISHING THE EEC , THE COMMUNITY MAY CONCLUDE AGREEMENTS WITH OTHER STATES INVOLVED IN EUROPEAN COOPERATION IN THE FIELD OF SCIENTIFIC AND TECHNICAL RESEARCH ( COST ) WITH A VIEW TO EXTENDING THE COORDINATION WHICH IS THE SUBJECT OF THIS DECISION TO RESEARCH UNDERTAKEN IN THESE STATES .

2 . THE COMMISSION IS HEREBY AUTHORIZED TO OPEN NEGOTIATIONS FOR THE CONCLUSION OF AGREEMENTS OF THE TYPE REFERRED TO IN THE PRECEDING PARAGRAPH .

ARTICLE 7

THIS DECISION SHALL COME INTO FORCE ON 1 JANUARY 1978 .

DONE AT BRUSSELS , 13 FEBRUARY 1978 .

FOR THE COUNCIL

THE PRESIDENT

P . DALSAGER

ANNEX I

RESEARCH PROGRAMME RELATING TO THE REGISTRATION OF CONGENITAL ABNORMALITIES

( CONCERTED PROJECT )

THE RESEARCH WILL BE CARRIED OUT WITH THE PURPOSE OF ACQUIRING SCIENTIFIC AND TECHNICAL KNOWLEDGE IN THIS FIELD , SELECTED FOR ITS IMPORTANCE AT COMMUNITY LEVEL .

THE RESEARCH IS EXPECTED TO COVER THE FOLLOWING TOPICS :

1 . REGISTRATION OF CONGENITAL MALFORMATIONS AS WELL AS OF INHERITED BIOCHEMICAL AND CHROMOSOME ABNORMALITIES IN SELECTED REGIONS OF THE COMMUNITY . THE REGISTRATION WILL PROGRESSIVELY EXTEND TO ABNORMALITIES OF THE NERVOUS SYSTEM ( ANENCEPHALY , SPINA BIFIDA , ETC .), DOWN ' S SYNDROME , GROSS ABNORMALITIES OF THE LIMBS , MULTIPLE ABNORMALITIES , PHENYLKETONURIA AND COELIAC DISEASE .

2 . REGISTRATION OF TWINS AND MULTIPLE PREGNANCIES IN SELECTED REGIONS OF THE COMMUNITY .

3 . RELEVANT METHODOLOGICAL STUDIES IN ORDER TO OBTAIN AN OPTIMAL COORDINATION OF BOTH EXISTING NATIONAL REGISTERS AND REGISTRATION PROCEDURES .

THE COORDINATION WILL INCLUDE THE FOLLOWING REGIONAL REGISTERS OF THE MEMBER STATES :

// BELGIUM : // BRUGGE AND HAINAUT . //

DENMARK : // ODENSE . //

FRANCE : // PARIS . //

GERMANY : // HESSEN . //

IRELAND : // DUBLIN AND GALWAY . //

ITALY : // FLORENCE AND ROME . //

LUXEMBOURG : // LUXEMBOURG . //

NETHERLANDS : // LEIDSCHENDAM . //

UNITED KINGDOM : // BELFAST , GLASGOW AND LIVERPOOL . //

THESE COUNTRIES WILL CONTRIBUTE RESEARCH UNDER THE THREE TOPICS MENTIONED ABOVE .

ANNEX II

TERMS OF REFERENCE AND COMPOSITION OF THE CONCERTED ACTION COMMITTEE ON THE REGISTRATION OF CONGENITAL ABNORMALITIES

1 . THE COMMITTEE SHALL :

1.1 . CONTRIBUTE TO THE OPTIMUM EXECUTION OF THE PROGRAMME BY GIVING ITS OPINION ON ALL OF ITS ASPECTS ;

1.2 . EVALUATE THE RESULTS AND DRAW CONCLUSIONS AS REGARDS THEIR APPLICATION ;

1.3 . BE RESPONSIBLE FOR THE EXCHANGE OF INFORMATION REFERRED TO IN THE FIRST SUBPARAGRAPH OF ARTICLE 5 ;

1.4 . KEEP ABREAST OF NATIONAL RESEARCH BEING DONE IN THE FIELDS COVERED BY THE CONCERTED PROJECT , AND MORE ESPECIALLY OF SCIENTIFIC AND TECHNICAL DEVELOPMENTS LIKELY TO AFFECT THE EXECUTION OF THE PROJECT ;

1.5 . SUGGEST GUIDELINES TO THE PROJECT LEADER .

2 . THE COMMITTEE ' S REPORTS AND OPINIONS SHALL BE FORWARDED TO THE COMMISSION AND TO THE MEMBER STATES PARTICIPATING IN THE PROJECT . THE COMMISSION SHALL FORWARD THESE OPINIONS TO THE CREST .

3 . THE COMMITTEE SHALL BE COMPOSED OF PERSONS RESPONSIBLE FOR COORDINATING THE NATIONAL CONTRIBUTIONS TO THE PROGRAMME , AND THE PROJECT LEADER . EACH MEMBER MAY BE ACCOMPANIED BY EXPERTS .